Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 16.26% |
| 3 | Financials | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Golar LNG
GLNG
$5.25B
| $2.77M | 0.01% |
121,753
+95,505
| +364% | +$2.39M |
|
|
SCS
1127
DELISTED
Steelcase
SCS
| $2.76M | 0.01% |
390,701
+363,938
| +1,360% | +$2.69M |
|
1128
LivaNova
LIVN
$4.31B
| $2.75M | 0.01% |
49,633
+26,613
| +116% | +$1.36M |
|
1129
Northwest Natural Holdings
NWN
$2.11B
| $2.74M | 0.01% |
57,571
-305
| -0.5% | -$14.3K |
|
1130
Winmark
WINA
$1.26B
| $2.73M | 0.01% |
11,594
-1,636
| -12% | -$390K |
|
1131
Omega Healthcare
OHI
$14.1B
| $2.73M | 0.01% |
98,086
+20,138
| +26% | +$607K |
|
1132
Resideo Technologies
REZI
$2.93B
| $2.72M | 0.01% |
165,320
+126,032
| +321% | +$2.29M |
|
1133
Towne Bank
TOWN
$3.5B
| $2.71M | 0.01% |
87,930
-841
| -0.9% | -$26.1K |
|
1134
Sonic Automotive
SAH
$2.38B
| $2.71M | 0.01% |
54,945
+28,195
| +105% | +$1.35M |
|
1135
Quanterix
QTRX
$132M
| $2.7M | 0.01% |
195,221
-112,264
| -37% | -$1.29M |
|
1136
Winnebago Industries
WGO
$909M
| $2.69M | 0.01% |
51,000
+10,324
| +25% | +$587K |
|
1137
Alexandria Real Estate Equities
ARE
$9.3B
| $2.67M | 0.01% |
18,502
-782
| -4% | -$113K |
|
1138
Asbury Automotive
ABG
$3.79B
| $2.67M | 0.01% |
14,869
+3,436
| +30% | +$575K |
|
1139
Amerant Bancorp
AMTB
$1.13B
| $2.66M | 0.01% |
99,249
-4,782
| -5% | -$134K |
|
1140
UDR
UDR
$12.3B
| $2.66M | 0.01% |
68,833
+11,028
| +19% | +$436K |
|
1141
QCR Holdings
QCRH
$1.65B
| $2.65M | 0.01% |
53,417
+15,688
| +42% | +$808K |
|
1142
AMERISAFE
AMSF
$490M
| $2.64M | 0.01% |
50,894
-18,489
| -27% | -$979K |
|
1143
Spire
SR
$4.87B
| $2.64M | 0.01% |
38,283
-1,058
| -3% | -$72K |
|
|
WW
1144
DELISTED
WW International
WW
| $2.63M | 0.01% |
692,543
-109,279
| -14% | -$438K |
|
1145
Oceaneering
OII
$5.02B
| $2.63M | 0.01% |
150,106
-181,432
| -55% | -$2.41M |
|
1146
Ciena
CIEN
$52.7B
| $2.62M | 0.01% |
51,795
-53,812
| -51% | -$2.43M |
|
1147
Dillards
DDS
$10B
| $2.61M | 0.01% |
8,079
-1,146
| -12% | -$373K |
|
1148
Sally Beauty Holdings
SBH
$1.56B
| $2.6M | 0.01% |
208,017
+159,655
| +330% | +$1.96M |
|
1149
Axcelis
ACLS
$3.81B
| $2.59M | 0.01% |
32,610
-17,236
| -35% | -$1.21M |
|
1150
Calix
CALX
$2.51B
| $2.59M | 0.01% |
38,144
-24,045
| -39% | -$1.62M |
|
Similar funds
Cliff Asness's Q4 2022 Portfolio in Review
As of Q4 2022, Cliff Asness held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Cliff Asness's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- Cliff Asness added most to Humana in Q4 2022, an estimated $111M increase.
- Cliff Asness's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- Cliff Asness fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- Cliff Asness's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- Cliff Asness opened 170 new positions and closed 150 in Q4 2022.
- Cliff Asness's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.